Search research articles
Contact Us
Filters
Showing results (121-130 of 137) with videos related to
Page
of 14
Sort By:
Journal of the National Cancer Institute
|
September 25, 1998
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
B Fisher, J P Costantino, D L Wickerham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 23, 2020
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
M E Salem, J Yin, R M Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil
B Fisher, J Dignam, E P Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23
B Fisher, S Anderson, E Tan-Chiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2023
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
B Fisher, J Bryant, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
B Fisher, J Bryant, N Wolmark, et al.
ESMO Open
|
March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis
R Cohen, M Raeisi, B Chibaudel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22
B Fisher, S Anderson, D L Wickerham, et al.
American Journal of Ophthalmology
|
April 29, 1998
Long-term tamoxifen citrate use and potential ocular toxicity
M B Gorin, R Day, J P Costantino, et al.
Journal of the National Cancer Institute
|
March 4, 2000
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
N Wolmark, H S Wieand, D M Hyams, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 137) with videos related to
Sort By:
Page
of 14
Journal of the National Cancer Institute
|
September 25, 1998
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
B Fisher, J P Costantino, D L Wickerham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 23, 2020
Evaluation of the change of outcomes over a 10-year period in patients with stage III colon cancer: pooled analysis of 6501 patients treated with fluorouracil, leucovorin, and oxaliplatin in the ACCENT database
M E Salem, J Yin, R M Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil
B Fisher, J Dignam, E P Mamounas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23
B Fisher, S Anderson, E Tan-Chiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2023
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
B Fisher, J Bryant, N Wolmark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 1998
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
B Fisher, J Bryant, N Wolmark, et al.
ESMO Open
|
March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis
R Cohen, M Raeisi, B Chibaudel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22
B Fisher, S Anderson, D L Wickerham, et al.
American Journal of Ophthalmology
|
April 29, 1998
Long-term tamoxifen citrate use and potential ocular toxicity
M B Gorin, R Day, J P Costantino, et al.
Journal of the National Cancer Institute
|
March 4, 2000
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
N Wolmark, H S Wieand, D M Hyams, et al.
Page
of 14